ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pre-Menstrual Syndrome Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-8S6205
Home | Market Reports | Health| Reproductive Health
Global Pre Menstrual Syndrome Market Insights and Forecast to 2028
BUY CHAPTERS

Global Pre-Menstrual Syndrome Market Insights, Forecast to 2030

Code: QYRE-Auto-8S6205
Report
December 2024
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Alva-Amco Pharmacal Cos., Inc.
Bayer
Chattem, Inc. (Sanofi)
DEKK-TEC, Inc.
G. R. Lane Health Products Ltd
McNeil Consumer Healthcare
MetP Pharma AG
Pherin Pharmaceuticals Inc
Umecrine Mood AB
Novartis
GlaxoSmithKline PLC

Pre-Menstrual Syndrome Market

Pre-menstrual syndrome (PMS) is defined as a condition that affects women at childbearing age and is characterized by symptoms such as bloating, pain, breast tenderness, body pain, fatigue, mood fluctuation, anxiety, etc.
Market Analysis and Insights: Global Pre-Menstrual Syndrome Market
The global Pre-Menstrual Syndrome market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Pre-Menstrual Syndrome is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Pre-Menstrual Syndrome is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Pre-Menstrual Syndrome is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Pre-Menstrual Syndrome include Alva-Amco Pharmacal Cos., Inc., Bayer, Inc., Chattem, Inc. (Sanofi), DEKK-TEC, Inc., G. R. Lane Health Products Ltd, McNeil Consumer Healthcare, MetP Pharma AG, Pherin Pharmaceuticals, Inc. and Umecrine Mood AB, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Pre-Menstrual Syndrome is widely used in various fields, such as Hospitals, Clinic and Others,, etc. Hospitals provides greatest supports to the Pre-Menstrual Syndrome industry development. In 2023, global % revenue of Pre-Menstrual Syndrome went into Hospitals filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Pre-Menstrual Syndrome market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pre-Menstrual Syndrome, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Pre-Menstrual Syndrome, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pre-Menstrual Syndrome revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Pre-Menstrual Syndrome market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Pre-Menstrual Syndrome revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Pre-Menstrual Syndrome Market Report

Report Metric Details
Report Name Pre-Menstrual Syndrome Market
Segment by Type
Segment by Application
  • Hospitals
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Alva-Amco Pharmacal Cos., Inc., Bayer, Inc., Chattem, Inc. (Sanofi), DEKK-TEC, Inc., G. R. Lane Health Products Ltd, McNeil Consumer Healthcare, MetP Pharma AG, Pherin Pharmaceuticals, Inc., Umecrine Mood AB, Novartis AG, GlaxoSmithKline Plc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Pre-Menstrual Syndrome in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pre-Menstrual Syndrome companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pre-Menstrual Syndrome revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Pre-Menstrual Syndrome Market report?

Ans: The main players in the Pre-Menstrual Syndrome Market are Alva-Amco Pharmacal Cos., Inc., Bayer, Inc., Chattem, Inc. (Sanofi), DEKK-TEC, Inc., G. R. Lane Health Products Ltd, McNeil Consumer Healthcare, MetP Pharma AG, Pherin Pharmaceuticals, Inc., Umecrine Mood AB, Novartis AG, GlaxoSmithKline Plc

What are the Application segmentation covered in the Pre-Menstrual Syndrome Market report?

Ans: The Applications covered in the Pre-Menstrual Syndrome Market report are Hospitals, Clinic, Others

What are the Type segmentation covered in the Pre-Menstrual Syndrome Market report?

Ans: The Types covered in the Pre-Menstrual Syndrome Market report are Analgesics (Pain Killers), Oral Contraceptive Pills (OCPs), Gonadotropin-Releasing Hormone (GnRH), Antidepressants, Ovarian Suppressors, Diuretics, Benzodiazepines

Recommended Reports

Gynecological Disorders

Menstrual Health Products

Pregnancy & Postpartum

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pre-Menstrual Syndrome Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Analgesics (Pain Killers)
1.2.3 Oral Contraceptive Pills (OCPs)
1.2.4 Gonadotropin-Releasing Hormone (GnRH)
1.2.5 Antidepressants
1.2.6 Ovarian Suppressors
1.2.7 Diuretics
1.2.8 Benzodiazepines
1.3 Market by Application
1.3.1 Global Pre-Menstrual Syndrome Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pre-Menstrual Syndrome Market Perspective (2019-2030)
2.2 Global Pre-Menstrual Syndrome Growth Trends by Region
2.2.1 Pre-Menstrual Syndrome Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pre-Menstrual Syndrome Historic Market Size by Region (2019-2024)
2.2.3 Pre-Menstrual Syndrome Forecasted Market Size by Region (2025-2030)
2.3 Pre-Menstrual Syndrome Market Dynamics
2.3.1 Pre-Menstrual Syndrome Industry Trends
2.3.2 Pre-Menstrual Syndrome Market Drivers
2.3.3 Pre-Menstrual Syndrome Market Challenges
2.3.4 Pre-Menstrual Syndrome Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Pre-Menstrual Syndrome by Players
3.1.1 Global Pre-Menstrual Syndrome Revenue by Players (2019-2024)
3.1.2 Global Pre-Menstrual Syndrome Revenue Market Share by Players (2019-2024)
3.2 Global Pre-Menstrual Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Pre-Menstrual Syndrome, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Pre-Menstrual Syndrome Market Concentration Ratio
3.4.1 Global Pre-Menstrual Syndrome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pre-Menstrual Syndrome Revenue in 2023
3.5 Global Key Players of Pre-Menstrual Syndrome Head office and Area Served
3.6 Global Key Players of Pre-Menstrual Syndrome, Product and Application
3.7 Global Key Players of Pre-Menstrual Syndrome, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pre-Menstrual Syndrome Breakdown Data by Type
4.1 Global Pre-Menstrual Syndrome Historic Market Size by Type (2019-2024)
4.2 Global Pre-Menstrual Syndrome Forecasted Market Size by Type (2025-2030)
5 Pre-Menstrual Syndrome Breakdown Data by Application
5.1 Global Pre-Menstrual Syndrome Historic Market Size by Application (2019-2024)
5.2 Global Pre-Menstrual Syndrome Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pre-Menstrual Syndrome Market Size (2019-2030)
6.2 North America Pre-Menstrual Syndrome Market Size by Type
6.2.1 North America Pre-Menstrual Syndrome Market Size by Type (2019-2024)
6.2.2 North America Pre-Menstrual Syndrome Market Size by Type (2025-2030)
6.2.3 North America Pre-Menstrual Syndrome Market Share by Type (2019-2030)
6.3 North America Pre-Menstrual Syndrome Market Size by Application
6.3.1 North America Pre-Menstrual Syndrome Market Size by Application (2019-2024)
6.3.2 North America Pre-Menstrual Syndrome Market Size by Application (2025-2030)
6.3.3 North America Pre-Menstrual Syndrome Market Share by Application (2019-2030)
6.4 North America Pre-Menstrual Syndrome Market Size by Country
6.4.1 North America Pre-Menstrual Syndrome Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Pre-Menstrual Syndrome Market Size by Country (2019-2024)
6.4.3 North America Pre-Menstrual Syndrome Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Pre-Menstrual Syndrome Market Size (2019-2030)
7.2 Europe Pre-Menstrual Syndrome Market Size by Type
7.2.1 Europe Pre-Menstrual Syndrome Market Size by Type (2019-2024)
7.2.2 Europe Pre-Menstrual Syndrome Market Size by Type (2025-2030)
7.2.3 Europe Pre-Menstrual Syndrome Market Share by Type (2019-2030)
7.3 Europe Pre-Menstrual Syndrome Market Size by Application
7.3.1 Europe Pre-Menstrual Syndrome Market Size by Application (2019-2024)
7.3.2 Europe Pre-Menstrual Syndrome Market Size by Application (2025-2030)
7.3.3 Europe Pre-Menstrual Syndrome Market Share by Application (2019-2030)
7.4 Europe Pre-Menstrual Syndrome Market Size by Country
7.4.1 Europe Pre-Menstrual Syndrome Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Pre-Menstrual Syndrome Market Size by Country (2019-2024)
7.4.3 Europe Pre-Menstrual Syndrome Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Pre-Menstrual Syndrome Market Size (2019-2030)
8.2 China Pre-Menstrual Syndrome Market Size by Type
8.2.1 China Pre-Menstrual Syndrome Market Size by Type (2019-2024)
8.2.2 China Pre-Menstrual Syndrome Market Size by Type (2025-2030)
8.2.3 China Pre-Menstrual Syndrome Market Share by Type (2019-2030)
8.3 China Pre-Menstrual Syndrome Market Size by Application
8.3.1 China Pre-Menstrual Syndrome Market Size by Application (2019-2024)
8.3.2 China Pre-Menstrual Syndrome Market Size by Application (2025-2030)
8.3.3 China Pre-Menstrual Syndrome Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Pre-Menstrual Syndrome Market Size (2019-2030)
9.2 Asia Pre-Menstrual Syndrome Market Size by Type
9.2.1 Asia Pre-Menstrual Syndrome Market Size by Type (2019-2024)
9.2.2 Asia Pre-Menstrual Syndrome Market Size by Type (2025-2030)
9.2.3 Asia Pre-Menstrual Syndrome Market Share by Type (2019-2030)
9.3 Asia Pre-Menstrual Syndrome Market Size by Application
9.3.1 Asia Pre-Menstrual Syndrome Market Size by Application (2019-2024)
9.3.2 Asia Pre-Menstrual Syndrome Market Size by Application (2025-2030)
9.3.3 Asia Pre-Menstrual Syndrome Market Share by Application (2019-2030)
9.4 Asia Pre-Menstrual Syndrome Market Size by Region
9.4.1 Asia Pre-Menstrual Syndrome Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Pre-Menstrual Syndrome Market Size by Region (2019-2024)
9.4.3 Asia Pre-Menstrual Syndrome Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Pre-Menstrual Syndrome Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Pre-Menstrual Syndrome Market Size by Type
10.2.1 Middle East, Africa, and Latin America Pre-Menstrual Syndrome Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Pre-Menstrual Syndrome Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Pre-Menstrual Syndrome Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Pre-Menstrual Syndrome Market Size by Application
10.3.1 Middle East, Africa, and Latin America Pre-Menstrual Syndrome Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Pre-Menstrual Syndrome Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Pre-Menstrual Syndrome Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Pre-Menstrual Syndrome Market Size by Country
10.4.1 Middle East, Africa, and Latin America Pre-Menstrual Syndrome Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Pre-Menstrual Syndrome Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Pre-Menstrual Syndrome Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Alva-Amco Pharmacal Cos., Inc.
11.1.1 Alva-Amco Pharmacal Cos., Inc. Company Details
11.1.2 Alva-Amco Pharmacal Cos., Inc. Business Overview
11.1.3 Alva-Amco Pharmacal Cos., Inc. Pre-Menstrual Syndrome Introduction
11.1.4 Alva-Amco Pharmacal Cos., Inc. Revenue in Pre-Menstrual Syndrome Business (2019-2024)
11.1.5 Alva-Amco Pharmacal Cos., Inc. Recent Developments
11.2 Bayer, Inc.
11.2.1 Bayer, Inc. Company Details
11.2.2 Bayer, Inc. Business Overview
11.2.3 Bayer, Inc. Pre-Menstrual Syndrome Introduction
11.2.4 Bayer, Inc. Revenue in Pre-Menstrual Syndrome Business (2019-2024)
11.2.5 Bayer, Inc. Recent Developments
11.3 Chattem, Inc. (Sanofi)
11.3.1 Chattem, Inc. (Sanofi) Company Details
11.3.2 Chattem, Inc. (Sanofi) Business Overview
11.3.3 Chattem, Inc. (Sanofi) Pre-Menstrual Syndrome Introduction
11.3.4 Chattem, Inc. (Sanofi) Revenue in Pre-Menstrual Syndrome Business (2019-2024)
11.3.5 Chattem, Inc. (Sanofi) Recent Developments
11.4 DEKK-TEC, Inc.
11.4.1 DEKK-TEC, Inc. Company Details
11.4.2 DEKK-TEC, Inc. Business Overview
11.4.3 DEKK-TEC, Inc. Pre-Menstrual Syndrome Introduction
11.4.4 DEKK-TEC, Inc. Revenue in Pre-Menstrual Syndrome Business (2019-2024)
11.4.5 DEKK-TEC, Inc. Recent Developments
11.5 G. R. Lane Health Products Ltd
11.5.1 G. R. Lane Health Products Ltd Company Details
11.5.2 G. R. Lane Health Products Ltd Business Overview
11.5.3 G. R. Lane Health Products Ltd Pre-Menstrual Syndrome Introduction
11.5.4 G. R. Lane Health Products Ltd Revenue in Pre-Menstrual Syndrome Business (2019-2024)
11.5.5 G. R. Lane Health Products Ltd Recent Developments
11.6 McNeil Consumer Healthcare
11.6.1 McNeil Consumer Healthcare Company Details
11.6.2 McNeil Consumer Healthcare Business Overview
11.6.3 McNeil Consumer Healthcare Pre-Menstrual Syndrome Introduction
11.6.4 McNeil Consumer Healthcare Revenue in Pre-Menstrual Syndrome Business (2019-2024)
11.6.5 McNeil Consumer Healthcare Recent Developments
11.7 MetP Pharma AG
11.7.1 MetP Pharma AG Company Details
11.7.2 MetP Pharma AG Business Overview
11.7.3 MetP Pharma AG Pre-Menstrual Syndrome Introduction
11.7.4 MetP Pharma AG Revenue in Pre-Menstrual Syndrome Business (2019-2024)
11.7.5 MetP Pharma AG Recent Developments
11.8 Pherin Pharmaceuticals, Inc.
11.8.1 Pherin Pharmaceuticals, Inc. Company Details
11.8.2 Pherin Pharmaceuticals, Inc. Business Overview
11.8.3 Pherin Pharmaceuticals, Inc. Pre-Menstrual Syndrome Introduction
11.8.4 Pherin Pharmaceuticals, Inc. Revenue in Pre-Menstrual Syndrome Business (2019-2024)
11.8.5 Pherin Pharmaceuticals, Inc. Recent Developments
11.9 Umecrine Mood AB
11.9.1 Umecrine Mood AB Company Details
11.9.2 Umecrine Mood AB Business Overview
11.9.3 Umecrine Mood AB Pre-Menstrual Syndrome Introduction
11.9.4 Umecrine Mood AB Revenue in Pre-Menstrual Syndrome Business (2019-2024)
11.9.5 Umecrine Mood AB Recent Developments
11.10 Novartis AG
11.10.1 Novartis AG Company Details
11.10.2 Novartis AG Business Overview
11.10.3 Novartis AG Pre-Menstrual Syndrome Introduction
11.10.4 Novartis AG Revenue in Pre-Menstrual Syndrome Business (2019-2024)
11.10.5 Novartis AG Recent Developments
11.11 GlaxoSmithKline Plc
11.11.1 GlaxoSmithKline Plc Company Details
11.11.2 GlaxoSmithKline Plc Business Overview
11.11.3 GlaxoSmithKline Plc Pre-Menstrual Syndrome Introduction
11.11.4 GlaxoSmithKline Plc Revenue in Pre-Menstrual Syndrome Business (2019-2024)
11.11.5 GlaxoSmithKline Plc Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Alva-Amco Pharmacal Cos., Inc.
Bayer
Chattem, Inc. (Sanofi)
DEKK-TEC, Inc.
G. R. Lane Health Products Ltd
McNeil Consumer Healthcare
MetP Pharma AG
Pherin Pharmaceuticals Inc
Umecrine Mood AB
Novartis
GlaxoSmithKline PLC
List of Tables
    Table 1. Global Pre-Menstrual Syndrome Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Analgesics (Pain Killers)
    Table 3. Key Players of Oral Contraceptive Pills (OCPs)
    Table 4. Key Players of Gonadotropin-Releasing Hormone (GnRH)
    Table 5. Key Players of Antidepressants
    Table 6. Key Players of Ovarian Suppressors
    Table 7. Key Players of Diuretics
    Table 8. Key Players of Benzodiazepines
    Table 9. Global Pre-Menstrual Syndrome Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 10. Global Pre-Menstrual Syndrome Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 11. Global Pre-Menstrual Syndrome Market Size by Region (2019-2024) & (US$ Million)
    Table 12. Global Pre-Menstrual Syndrome Market Share by Region (2019-2024)
    Table 13. Global Pre-Menstrual Syndrome Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 14. Global Pre-Menstrual Syndrome Market Share by Region (2025-2030)
    Table 15. Pre-Menstrual Syndrome Market Trends
    Table 16. Pre-Menstrual Syndrome Market Drivers
    Table 17. Pre-Menstrual Syndrome Market Challenges
    Table 18. Pre-Menstrual Syndrome Market Restraints
    Table 19. Global Pre-Menstrual Syndrome Revenue by Players (2019-2024) & (US$ Million)
    Table 20. Global Pre-Menstrual Syndrome Revenue Share by Players (2019-2024)
    Table 21. Global Top Pre-Menstrual Syndrome by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pre-Menstrual Syndrome as of 2023)
    Table 22. Global Pre-Menstrual Syndrome Industry Ranking 2022 VS 2023 VS 2024
    Table 23. Global 5 Largest Players Market Share by Pre-Menstrual Syndrome Revenue (CR5 and HHI) & (2019-2024)
    Table 24. Global Key Players of Pre-Menstrual Syndrome, Headquarters and Area Served
    Table 25. Global Key Players of Pre-Menstrual Syndrome, Product and Application
    Table 26. Global Key Players of Pre-Menstrual Syndrome, Product and Application
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Pre-Menstrual Syndrome Market Size by Type (2019-2024) & (US$ Million)
    Table 29. Global Pre-Menstrual Syndrome Revenue Market Share by Type (2019-2024)
    Table 30. Global Pre-Menstrual Syndrome Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 31. Global Pre-Menstrual Syndrome Revenue Market Share by Type (2025-2030)
    Table 32. Global Pre-Menstrual Syndrome Market Size by Application (2019-2024) & (US$ Million)
    Table 33. Global Pre-Menstrual Syndrome Revenue Share by Application (2019-2024)
    Table 34. Global Pre-Menstrual Syndrome Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 35. Global Pre-Menstrual Syndrome Revenue Share by Application (2025-2030)
    Table 36. North America Pre-Menstrual Syndrome Market Size by Type (2019-2024) & (US$ Million)
    Table 37. North America Pre-Menstrual Syndrome Market Size by Type (2025-2030) & (US$ Million)
    Table 38. North America Pre-Menstrual Syndrome Market Size by Application (2019-2024) & (US$ Million)
    Table 39. North America Pre-Menstrual Syndrome Market Size by Application (2025-2030) & (US$ Million)
    Table 40. North America Pre-Menstrual Syndrome Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. North America Pre-Menstrual Syndrome Market Size by Country (2019-2024) & (US$ Million)
    Table 42. North America Pre-Menstrual Syndrome Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Europe Pre-Menstrual Syndrome Market Size by Type (2019-2024) & (US$ Million)
    Table 44. Europe Pre-Menstrual Syndrome Market Size by Type (2025-2030) & (US$ Million)
    Table 45. Europe Pre-Menstrual Syndrome Market Size by Application (2019-2024) & (US$ Million)
    Table 46. Europe Pre-Menstrual Syndrome Market Size by Application (2025-2030) & (US$ Million)
    Table 47. Europe Pre-Menstrual Syndrome Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 48. Europe Pre-Menstrual Syndrome Market Size by Country (2019-2024) & (US$ Million)
    Table 49. Europe Pre-Menstrual Syndrome Market Size by Country (2025-2030) & (US$ Million)
    Table 50. China Pre-Menstrual Syndrome Market Size by Type (2019-2024) & (US$ Million)
    Table 51. China Pre-Menstrual Syndrome Market Size by Type (2025-2030) & (US$ Million)
    Table 52. China Pre-Menstrual Syndrome Market Size by Application (2019-2024) & (US$ Million)
    Table 53. China Pre-Menstrual Syndrome Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Pre-Menstrual Syndrome Market Size by Type (2019-2024) & (US$ Million)
    Table 55. Asia Pre-Menstrual Syndrome Market Size by Type (2025-2030) & (US$ Million)
    Table 56. Asia Pre-Menstrual Syndrome Market Size by Application (2019-2024) & (US$ Million)
    Table 57. Asia Pre-Menstrual Syndrome Market Size by Application (2025-2030) & (US$ Million)
    Table 58. Asia Pre-Menstrual Syndrome Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 59. Asia Pre-Menstrual Syndrome Market Size by Region (2019-2024) & (US$ Million)
    Table 60. Asia Pre-Menstrual Syndrome Market Size by Region (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Pre-Menstrual Syndrome Market Size by Type (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Pre-Menstrual Syndrome Market Size by Type (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Pre-Menstrual Syndrome Market Size by Application (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Pre-Menstrual Syndrome Market Size by Application (2025-2030) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Pre-Menstrual Syndrome Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 66. Middle East, Africa, and Latin America Pre-Menstrual Syndrome Market Size by Country (2019-2024) & (US$ Million)
    Table 67. Middle East, Africa, and Latin America Pre-Menstrual Syndrome Market Size by Country (2025-2030) & (US$ Million)
    Table 68. Alva-Amco Pharmacal Cos., Inc. Company Details
    Table 69. Alva-Amco Pharmacal Cos., Inc. Business Overview
    Table 70. Alva-Amco Pharmacal Cos., Inc. Pre-Menstrual Syndrome Product
    Table 71. Alva-Amco Pharmacal Cos., Inc. Revenue in Pre-Menstrual Syndrome Business (2019-2024) & (US$ Million)
    Table 72. Alva-Amco Pharmacal Cos., Inc. Recent Developments
    Table 73. Bayer, Inc. Company Details
    Table 74. Bayer, Inc. Business Overview
    Table 75. Bayer, Inc. Pre-Menstrual Syndrome Product
    Table 76. Bayer, Inc. Revenue in Pre-Menstrual Syndrome Business (2019-2024) & (US$ Million)
    Table 77. Bayer, Inc. Recent Developments
    Table 78. Chattem, Inc. (Sanofi) Company Details
    Table 79. Chattem, Inc. (Sanofi) Business Overview
    Table 80. Chattem, Inc. (Sanofi) Pre-Menstrual Syndrome Product
    Table 81. Chattem, Inc. (Sanofi) Revenue in Pre-Menstrual Syndrome Business (2019-2024) & (US$ Million)
    Table 82. Chattem, Inc. (Sanofi) Recent Developments
    Table 83. DEKK-TEC, Inc. Company Details
    Table 84. DEKK-TEC, Inc. Business Overview
    Table 85. DEKK-TEC, Inc. Pre-Menstrual Syndrome Product
    Table 86. DEKK-TEC, Inc. Revenue in Pre-Menstrual Syndrome Business (2019-2024) & (US$ Million)
    Table 87. DEKK-TEC, Inc. Recent Developments
    Table 88. G. R. Lane Health Products Ltd Company Details
    Table 89. G. R. Lane Health Products Ltd Business Overview
    Table 90. G. R. Lane Health Products Ltd Pre-Menstrual Syndrome Product
    Table 91. G. R. Lane Health Products Ltd Revenue in Pre-Menstrual Syndrome Business (2019-2024) & (US$ Million)
    Table 92. G. R. Lane Health Products Ltd Recent Developments
    Table 93. McNeil Consumer Healthcare Company Details
    Table 94. McNeil Consumer Healthcare Business Overview
    Table 95. McNeil Consumer Healthcare Pre-Menstrual Syndrome Product
    Table 96. McNeil Consumer Healthcare Revenue in Pre-Menstrual Syndrome Business (2019-2024) & (US$ Million)
    Table 97. McNeil Consumer Healthcare Recent Developments
    Table 98. MetP Pharma AG Company Details
    Table 99. MetP Pharma AG Business Overview
    Table 100. MetP Pharma AG Pre-Menstrual Syndrome Product
    Table 101. MetP Pharma AG Revenue in Pre-Menstrual Syndrome Business (2019-2024) & (US$ Million)
    Table 102. MetP Pharma AG Recent Developments
    Table 103. Pherin Pharmaceuticals, Inc. Company Details
    Table 104. Pherin Pharmaceuticals, Inc. Business Overview
    Table 105. Pherin Pharmaceuticals, Inc. Pre-Menstrual Syndrome Product
    Table 106. Pherin Pharmaceuticals, Inc. Revenue in Pre-Menstrual Syndrome Business (2019-2024) & (US$ Million)
    Table 107. Pherin Pharmaceuticals, Inc. Recent Developments
    Table 108. Umecrine Mood AB Company Details
    Table 109. Umecrine Mood AB Business Overview
    Table 110. Umecrine Mood AB Pre-Menstrual Syndrome Product
    Table 111. Umecrine Mood AB Revenue in Pre-Menstrual Syndrome Business (2019-2024) & (US$ Million)
    Table 112. Umecrine Mood AB Recent Developments
    Table 113. Novartis AG Company Details
    Table 114. Novartis AG Business Overview
    Table 115. Novartis AG Pre-Menstrual Syndrome Product
    Table 116. Novartis AG Revenue in Pre-Menstrual Syndrome Business (2019-2024) & (US$ Million)
    Table 117. Novartis AG Recent Developments
    Table 118. GlaxoSmithKline Plc Company Details
    Table 119. GlaxoSmithKline Plc Business Overview
    Table 120. GlaxoSmithKline Plc Pre-Menstrual Syndrome Product
    Table 121. GlaxoSmithKline Plc Revenue in Pre-Menstrual Syndrome Business (2019-2024) & (US$ Million)
    Table 122. GlaxoSmithKline Plc Recent Developments
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pre-Menstrual Syndrome Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Pre-Menstrual Syndrome Market Share by Type: 2023 VS 2030
    Figure 3. Analgesics (Pain Killers) Features
    Figure 4. Oral Contraceptive Pills (OCPs) Features
    Figure 5. Gonadotropin-Releasing Hormone (GnRH) Features
    Figure 6. Antidepressants Features
    Figure 7. Ovarian Suppressors Features
    Figure 8. Diuretics Features
    Figure 9. Benzodiazepines Features
    Figure 10. Global Pre-Menstrual Syndrome Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 11. Global Pre-Menstrual Syndrome Market Share by Application: 2023 VS 2030
    Figure 12. Hospitals Case Studies
    Figure 13. Clinic Case Studies
    Figure 14. Others Case Studies
    Figure 15. Pre-Menstrual Syndrome Report Years Considered
    Figure 16. Global Pre-Menstrual Syndrome Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 17. Global Pre-Menstrual Syndrome Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 18. Global Pre-Menstrual Syndrome Market Share by Region: 2023 VS 2030
    Figure 19. Global Pre-Menstrual Syndrome Market Share by Players in 2023
    Figure 20. Global Top Pre-Menstrual Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pre-Menstrual Syndrome as of 2023)
    Figure 21. The Top 10 and 5 Players Market Share by Pre-Menstrual Syndrome Revenue in 2023
    Figure 22. North America Pre-Menstrual Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. North America Pre-Menstrual Syndrome Market Share by Type (2019-2030)
    Figure 24. North America Pre-Menstrual Syndrome Market Share by Application (2019-2030)
    Figure 25. North America Pre-Menstrual Syndrome Market Share by Country (2019-2030)
    Figure 26. United States Pre-Menstrual Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Canada Pre-Menstrual Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Europe Pre-Menstrual Syndrome Market Size YoY (2019-2030) & (US$ Million)
    Figure 29. Europe Pre-Menstrual Syndrome Market Share by Type (2019-2030)
    Figure 30. Europe Pre-Menstrual Syndrome Market Share by Application (2019-2030)
    Figure 31. Europe Pre-Menstrual Syndrome Market Share by Country (2019-2030)
    Figure 32. Germany Pre-Menstrual Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. France Pre-Menstrual Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. U.K. Pre-Menstrual Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Italy Pre-Menstrual Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Russia Pre-Menstrual Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Nordic Countries Pre-Menstrual Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. China Pre-Menstrual Syndrome Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. China Pre-Menstrual Syndrome Market Share by Type (2019-2030)
    Figure 40. China Pre-Menstrual Syndrome Market Share by Application (2019-2030)
    Figure 41. Asia Pre-Menstrual Syndrome Market Size YoY (2019-2030) & (US$ Million)
    Figure 42. Asia Pre-Menstrual Syndrome Market Share by Type (2019-2030)
    Figure 43. Asia Pre-Menstrual Syndrome Market Share by Application (2019-2030)
    Figure 44. Asia Pre-Menstrual Syndrome Market Share by Region (2019-2030)
    Figure 45. Japan Pre-Menstrual Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. South Korea Pre-Menstrual Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. China Taiwan Pre-Menstrual Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Southeast Asia Pre-Menstrual Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. India Pre-Menstrual Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Australia Pre-Menstrual Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Middle East, Africa, and Latin America Pre-Menstrual Syndrome Market Size YoY (2019-2030) & (US$ Million)
    Figure 52. Middle East, Africa, and Latin America Pre-Menstrual Syndrome Market Share by Type (2019-2030)
    Figure 53. Middle East, Africa, and Latin America Pre-Menstrual Syndrome Market Share by Application (2019-2030)
    Figure 54. Middle East, Africa, and Latin America Pre-Menstrual Syndrome Market Share by Country (2019-2030)
    Figure 55. Brazil Pre-Menstrual Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Mexico Pre-Menstrual Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Turkey Pre-Menstrual Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Saudi Arabia Pre-Menstrual Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Israel Pre-Menstrual Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. GCC Countries Pre-Menstrual Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 61. Alva-Amco Pharmacal Cos., Inc. Revenue Growth Rate in Pre-Menstrual Syndrome Business (2019-2024)
    Figure 62. Bayer, Inc. Revenue Growth Rate in Pre-Menstrual Syndrome Business (2019-2024)
    Figure 63. Chattem, Inc. (Sanofi) Revenue Growth Rate in Pre-Menstrual Syndrome Business (2019-2024)
    Figure 64. DEKK-TEC, Inc. Revenue Growth Rate in Pre-Menstrual Syndrome Business (2019-2024)
    Figure 65. G. R. Lane Health Products Ltd Revenue Growth Rate in Pre-Menstrual Syndrome Business (2019-2024)
    Figure 66. McNeil Consumer Healthcare Revenue Growth Rate in Pre-Menstrual Syndrome Business (2019-2024)
    Figure 67. MetP Pharma AG Revenue Growth Rate in Pre-Menstrual Syndrome Business (2019-2024)
    Figure 68. Pherin Pharmaceuticals, Inc. Revenue Growth Rate in Pre-Menstrual Syndrome Business (2019-2024)
    Figure 69. Umecrine Mood AB Revenue Growth Rate in Pre-Menstrual Syndrome Business (2019-2024)
    Figure 70. Novartis AG Revenue Growth Rate in Pre-Menstrual Syndrome Business (2019-2024)
    Figure 71. GlaxoSmithKline Plc Revenue Growth Rate in Pre-Menstrual Syndrome Business (2019-2024)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Premenstrual Dysphoric Disorder PMDD Market Insights Forecast to 2030
Global Phelan McDermid Syndrome PMS Market Research Report 2024
Global Irritable Bowel Syndrome IBS Market Insights Forecast to 2030
Polycystic Ovarian Syndrome PCOS Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Polycystic Ovary Syndrome Treatment Market Insights Forecast to 2030
Global Medical Practice Management PMS Market Insights Forecast to 2030
Global Women Health Diagnostics Market Insights Forecast to 2030
Global Medical Practice Management Software PMS Market Insights Forecast to 2030
Preeclampsia Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Premenstrual Syndrome Medicine Market Research Report 2025
Global Polycystic Ovary Syndrome PCOS Treatment Market Research Report 2024
Preeclampsia Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Menstrual Discs Market Research Report 2024
Global Women s Health Market Research Report 2025
Global PMS And Menstrual Health Supplements Market Research Report 2024
Premenstrual Syndrome Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Menopause Drugs Market Insights Forecast to 2030
Global Rx Irritable Bowel Syndrome IBS Drugs Market Insights Forecast to 2030
Global Polycystic Ovarian Syndrome PCOS Therapeutics Market Insights Forecast to 2030
Irritable Bowel Syndrome Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions